Factors at de novo donor‐specific antibody initial detection associated with allograft loss: a multicenter study

Carrie A. Schinstock(Mayo Clinic), Mark D. Stegall(Mayo Clinic in Arizona), Byron H. Smith(Mayo Clinic in Florida), Milagros Samaniego(Henry Ford Health System), Vijay K. Sharma(Cornell University), Matthew J. Everly(Terasaki Foundation), Darshana M. Dadhania(NewYork–Presbyterian Hospital), Evan A. Farkash(University of Michigan), Manish J. Gandhi(Mayo Clinic in Arizona)
Transplant International
December 31, 2018
10.1111/tri.13395
Cited by 22

Related Papers

A longitudinal study on the mental health of general population during the COVID-19 epidemic in China
|Brain Behavior and Immunity|2020|2.7k
A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak
|Brain Behavior and Immunity|2020|1.7k
Psychological Impact of the COVID-19 Pandemic on Health Care Workers in Singapore
|Annals of Internal Medicine|2020|1.3k
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k